CN103610056A - 供神经衰弱患者食用的胶囊及其生产工艺 - Google Patents
供神经衰弱患者食用的胶囊及其生产工艺 Download PDFInfo
- Publication number
- CN103610056A CN103610056A CN201310621903.7A CN201310621903A CN103610056A CN 103610056 A CN103610056 A CN 103610056A CN 201310621903 A CN201310621903 A CN 201310621903A CN 103610056 A CN103610056 A CN 103610056A
- Authority
- CN
- China
- Prior art keywords
- powder
- parts
- capsule
- neurastheniac
- pumpkin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 38
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 13
- 239000000843 powder Substances 0.000 claims abstract description 86
- 240000008042 Zea mays Species 0.000 claims abstract description 28
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 28
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 28
- 235000005822 corn Nutrition 0.000 claims abstract description 28
- 244000017020 Ipomoea batatas Species 0.000 claims abstract description 26
- 235000002678 Ipomoea batatas Nutrition 0.000 claims abstract description 26
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 23
- 241000251511 Holothuroidea Species 0.000 claims abstract description 22
- 235000020238 sunflower seed Nutrition 0.000 claims abstract description 19
- 244000068988 Glycine max Species 0.000 claims abstract description 17
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 14
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 14
- 235000013312 flour Nutrition 0.000 claims abstract description 12
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 4
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 4
- 239000011709 vitamin E Substances 0.000 claims abstract description 4
- 229940046009 vitamin E Drugs 0.000 claims abstract description 4
- 241000233866 Fungi Species 0.000 claims description 31
- 235000000832 Ayote Nutrition 0.000 claims description 25
- 235000009854 Cucurbita moschata Nutrition 0.000 claims description 25
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims description 25
- 235000015136 pumpkin Nutrition 0.000 claims description 25
- 235000013336 milk Nutrition 0.000 claims description 21
- 239000008267 milk Substances 0.000 claims description 21
- 210000004080 milk Anatomy 0.000 claims description 21
- 238000005516 engineering process Methods 0.000 claims description 12
- 238000005360 mashing Methods 0.000 claims description 9
- 238000005507 spraying Methods 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 8
- 240000001980 Cucurbita pepo Species 0.000 claims description 7
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 6
- 238000000227 grinding Methods 0.000 claims description 6
- 235000012054 meals Nutrition 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- 229940088594 vitamin Drugs 0.000 claims description 5
- 229930003231 vitamin Natural products 0.000 claims description 5
- 235000013343 vitamin Nutrition 0.000 claims description 5
- 239000011782 vitamin Substances 0.000 claims description 5
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 5
- 102000040350 B family Human genes 0.000 claims description 3
- 108091072128 B family Proteins 0.000 claims description 3
- 241000908178 Tremella fuciformis Species 0.000 claims description 3
- 238000003556 assay Methods 0.000 claims description 3
- 238000011049 filling Methods 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 3
- 235000001968 nicotinic acid Nutrition 0.000 claims description 3
- 229960003512 nicotinic acid Drugs 0.000 claims description 3
- 239000011664 nicotinic acid Substances 0.000 claims description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract description 30
- 230000000694 effects Effects 0.000 abstract description 29
- 210000000952 spleen Anatomy 0.000 abstract description 17
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 15
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract description 15
- 239000008280 blood Substances 0.000 abstract description 15
- 210000004369 blood Anatomy 0.000 abstract description 15
- 239000011575 calcium Substances 0.000 abstract description 15
- 229910052791 calcium Inorganic materials 0.000 abstract description 15
- 206010022437 insomnia Diseases 0.000 abstract description 15
- 229910052742 iron Inorganic materials 0.000 abstract description 15
- 206010003549 asthenia Diseases 0.000 abstract description 14
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 abstract description 14
- 210000002216 heart Anatomy 0.000 abstract description 13
- 208000007443 Neurasthenia Diseases 0.000 abstract description 12
- 210000003734 kidney Anatomy 0.000 abstract description 11
- 230000029087 digestion Effects 0.000 abstract description 9
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract description 9
- 239000011707 mineral Substances 0.000 abstract description 9
- 235000010755 mineral Nutrition 0.000 abstract description 9
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 abstract description 7
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract description 7
- 235000019152 folic acid Nutrition 0.000 abstract description 7
- 239000011724 folic acid Substances 0.000 abstract description 7
- 229960000304 folic acid Drugs 0.000 abstract description 7
- 238000005728 strengthening Methods 0.000 abstract description 7
- 239000011701 zinc Substances 0.000 abstract description 7
- 229910052725 zinc Inorganic materials 0.000 abstract description 7
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 abstract description 5
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract description 5
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 abstract description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract description 5
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 abstract description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 abstract description 5
- 239000010949 copper Substances 0.000 abstract description 5
- 229910052802 copper Inorganic materials 0.000 abstract description 5
- 239000011777 magnesium Substances 0.000 abstract description 5
- 229910052749 magnesium Inorganic materials 0.000 abstract description 5
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 abstract description 5
- 239000011733 molybdenum Substances 0.000 abstract description 5
- 229910052750 molybdenum Inorganic materials 0.000 abstract description 5
- 239000011591 potassium Substances 0.000 abstract description 5
- 229910052700 potassium Inorganic materials 0.000 abstract description 5
- 229910052708 sodium Inorganic materials 0.000 abstract description 5
- 239000011734 sodium Substances 0.000 abstract description 5
- 230000002269 spontaneous effect Effects 0.000 abstract description 5
- 235000019155 vitamin A Nutrition 0.000 abstract description 5
- 239000011719 vitamin A Substances 0.000 abstract description 5
- 229940045997 vitamin a Drugs 0.000 abstract description 5
- 241001506047 Tremella Species 0.000 abstract description 3
- 230000003647 oxidation Effects 0.000 abstract description 3
- 238000007254 oxidation reaction Methods 0.000 abstract description 3
- -1 phosophor Chemical compound 0.000 abstract description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract 1
- 241000219130 Cucurbita pepo subsp. pepo Species 0.000 abstract 1
- 235000003954 Cucurbita pepo var melopepo Nutrition 0.000 abstract 1
- 229930003779 Vitamin B12 Natural products 0.000 abstract 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract 1
- 230000032683 aging Effects 0.000 abstract 1
- 230000017531 blood circulation Effects 0.000 abstract 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 abstract 1
- 229920001592 potato starch Polymers 0.000 abstract 1
- 235000008476 powdered milk Nutrition 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 abstract 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 abstract 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 230000001502 supplementing effect Effects 0.000 abstract 1
- 235000019163 vitamin B12 Nutrition 0.000 abstract 1
- 239000011715 vitamin B12 Substances 0.000 abstract 1
- 235000019158 vitamin B6 Nutrition 0.000 abstract 1
- 239000011726 vitamin B6 Substances 0.000 abstract 1
- 229940011671 vitamin b6 Drugs 0.000 abstract 1
- 240000004244 Cucurbita moschata Species 0.000 description 18
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 16
- 210000004556 brain Anatomy 0.000 description 12
- 150000001413 amino acids Chemical class 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- 235000019640 taste Nutrition 0.000 description 10
- 235000013305 food Nutrition 0.000 description 9
- 201000010099 disease Diseases 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 230000036541 health Effects 0.000 description 7
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 6
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 6
- 235000013339 cereals Nutrition 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- 239000000787 lecithin Substances 0.000 description 6
- 229940067606 lecithin Drugs 0.000 description 6
- 235000010445 lecithin Nutrition 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 239000011574 phosphorus Substances 0.000 description 6
- 229910052698 phosphorus Inorganic materials 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 5
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- 229920002527 Glycogen Polymers 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 4
- 208000003351 Melanosis Diseases 0.000 description 4
- 239000005864 Sulphur Substances 0.000 description 4
- 208000007536 Thrombosis Diseases 0.000 description 4
- 208000009205 Tinnitus Diseases 0.000 description 4
- 230000003712 anti-aging effect Effects 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 210000004958 brain cell Anatomy 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 229940096919 glycogen Drugs 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- 235000008935 nutritious Nutrition 0.000 description 4
- 230000000050 nutritive effect Effects 0.000 description 4
- 230000008855 peristalsis Effects 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 230000035900 sweating Effects 0.000 description 4
- 231100000886 tinnitus Toxicity 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 210000002569 neuron Anatomy 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 2
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 2
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- 206010008570 Chloasma Diseases 0.000 description 2
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 2
- 206010012289 Dementia Diseases 0.000 description 2
- 208000020401 Depressive disease Diseases 0.000 description 2
- 206010013911 Dysgeusia Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 208000012895 Gastric disease Diseases 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- 206010018498 Goitre Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010019909 Hernia Diseases 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 208000036626 Mental retardation Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 108010019160 Pancreatin Proteins 0.000 description 2
- 206010036018 Pollakiuria Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010067868 Skin mass Diseases 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 2
- 229960004373 acetylcholine Drugs 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 231100000360 alopecia Toxicity 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000035603 choleresis Effects 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000010685 fatty oil Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000001156 gastric mucosa Anatomy 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 201000003872 goiter Diseases 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- 230000001631 hypertensive effect Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 208000024714 major depressive disease Diseases 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 201000003995 melancholia Diseases 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000007830 nerve conduction Effects 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 230000000422 nocturnal effect Effects 0.000 description 2
- 229940055695 pancreatin Drugs 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
- 235000015500 sitosterol Nutrition 0.000 description 2
- 229950005143 sitosterol Drugs 0.000 description 2
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 201000006347 Intellectual Disability Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- NHDHVHZZCFYRSB-UHFFFAOYSA-N pyriproxyfen Chemical compound C=1C=CC=NC=1OC(C)COC(C=C1)=CC=C1OC1=CC=CC=C1 NHDHVHZZCFYRSB-UHFFFAOYSA-N 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明涉及一种供神经衰弱患者食用的胶囊及其生产工艺,其特征在于:该胶囊采用了如下配方:牡蛎粉150份、海参粉100份、奶粉100份、鸡蛋粉80份、大豆粉80份、葵花子粉80份、银耳粉65份、南瓜粉65份、玉米粉50份、红薯粉50份。本发明所述的供神经衰弱患者食用的胶囊,选用了优质原料,含有丰富的维生素A、E、B6、B12、叶酸和蛋白质、矿物质,如:钙、铁、磷、锌、铜、锰、钼、钾、钠、镁、硫等,对如今常见的神经衰弱、失眠有治疗、改善作用,经常服用,能补肾益精、养血养心、健脾益气,促进血液循环、促进消化,达到抗氧化、防衰老,强身健体的作用。
Description
技术领域
本发明涉及食品加工领域,具体涉及一种供神经衰弱患者食用的胶囊及其生产工艺。
背景技术
神经衰弱的症状繁多,比较复杂,并且容易与其他疾病混淆,造成误诊。患者常感脑力不足、思维混乱、精神倦怠,这是最常见的神经衰弱特点之一。患者由于内抑制过程减弱,神经细胞易兴奋,能量消耗过多,往往表现为精力不足、萎靡不振、脑力迟钝、不能集中注意力、记忆力减退、工作效率减退等。
另外,敏感、多疑往往是最突出的神经衰弱的特点,并且有比较明显的睡眠障碍,常表现为入睡困难、睡眠不深、容易惊醒或睡眠时间太短,醒后又难以再睡等。长此以往,还容易出现生理心理障碍的症状,如头昏、眼花、心慌、胸闷、气短、尿频、多汗、阳萎、早泄、月经不调等。
由于社会竞争日益激烈,现代人很容易患上神经衰弱,导致神经衰弱的发病率日益上升。因此,如何预防神经衰弱就成为备受关注的一项重要课题。通过药物治疗有一定的副作用,所以一般人还是希望通过食疗的方式,来达到身体营养的完善与均衡。
发明内容
本发明就是针对上述现状,而提供一种供神经衰弱患者食用的胶囊及其生产工艺。
一种供神经衰弱患者食用的胶囊及其生产工艺,其特征在于:所述胶囊采用了如下配方及其生产工艺。
步骤1:挑选优质的牡蛎粉、海参粉、奶粉、鸡蛋粉、大豆、葵花子、银耳、南瓜、玉米和红薯为原料;
步骤2:将大豆炒熟后放入粉碎机中,经粗磨、细磨后打磨成细粉,过80-120目筛。
步骤3:将葵花子炒熟后放入粉碎机中,经粗磨、细磨后打磨成细粉,过80-120目筛。
步骤4:将银耳烘干或晒干后,研磨成细粉,过80-120目筛。
步骤5:将南瓜经去皮去籽→磨浆→滤渣→煮浆→调配→均质→浓缩→喷雾干燥后,过80-120目筛,得南瓜粉。
步骤6:将玉米经磨浆→滤渣→煮浆→调配→均质→浓缩→喷雾干燥后,过80-120目筛,得玉米粉。
步骤7:将红薯经去皮→磨浆→滤渣→煮浆→调配→均质→浓缩→喷雾干燥后,过80-120目筛,得红薯粉。
步骤8:称取上述牡蛎粉120-180份、海参粉80-120份、奶粉80-120份、鸡蛋粉60-100份、大豆粉60-100份、葵花子粉60-100份、银耳粉50-80份、南瓜粉50-80份、玉米粉40-60份、红薯粉40-60份。
步骤9:将上述粉剂放入搅拌机中搅拌均匀后,经杀菌后在无菌环境中灌装成胶囊,每粒0.25-0.5克,经检验合格后得成品。
本发明中的新型胶囊中主要原料的营养成分及功能如下。
上述牡蛎粉性微寒味咸与归经,归肝、胆、肾经,对神经衰弱、失眠有治疗、改善作用。《本草拾遗》:捣为粉,粉身,主大人小儿盗汗,和麻黄根、蛇床子、干姜为粉,去阴汗。《纲目》:化痰软坚,清热除湿,止心脾气痛,痢下,赤白浊,消疝瘕积块,瘿疾结核。
【功能与主治】重镇安神、潜阳补阴、软坚散结、收敛固涩,用于惊悸失眠、眩晕耳鸣、瘰疬痰核、自汗盗汗、遗精崩带、胃痛泛酸,能益阴潜阳,治阴虚阳亢之潮热、头痛、烦躁失眠等症。
上述海参粉由海参干制而成,对治疗神经衰弱、失眠有效果,海参的营养价值很高,蛋白质含量达70%,而胆固醇含量却较其它动物性食品都低,因此很适宜高血压病人食用。
中医认为,海参主人心、肺、脾、肾四经,是滋补气血津精的佳品。近年来发现,从海参中提取出的粘多糖,有抑制癌细胞生长和转移的功效;具有补肾益精,养血润肠的功效,适用于因肝肾亏损、精血不足引起的眩晕耳鸣、腰酸乏力、梦遗精、小便频繁者。
上述奶粉是由鲜牛奶消毒后经浓缩、喷雾、干燥而成的,具有健脾益气、补血养心作用,营养丰富,富含蛋白质、矿物质,如:钙、铁、磷、锌、铜、锰、钼以及维生素,可提供大脑所需的各种氨基酸,每天饮用可增强大脑活力。牛奶是一种近乎完美的营养品。它富含蛋白质、钙,及大脑所必需的氨基酸。牛奶中的钙最易被人吸收,是脑代谢不可缺少的重要物质。此外,它还含对神经细胞十分有益的维生素B1等元素。如果用脑过度而失眠时,睡前一杯热牛奶有助入睡。
上述鸡蛋粉由鸡蛋加工而成,有清肝泻火、养心安神作用,含有蛋黄素等脑细胞所必需的营养物质,可增强大脑活力。富含卵磷脂,是人体合成乙酰胆碱(负责记忆力的神经传导物质)的主要原料。此外,鸡蛋中也有丰富的维生素A、E、B6、B12、叶酸和锌等活化脑力很重要的营养素,尤其是叶酸和维生素B12。陆续有研究指出,如果长期缺乏这两种营养素,会使记忆力减退,甚至可能增加罹患失智症的机率。
上述大豆味甘、性平,入脾、大肠经,所含的卵磷脂是大脑细胞组成的重要部分,常吃黄豆对增加和改善大脑技能有重要的效能,且不含胆固醇,并可降低人体胆固醇,减少动脉硬化的发生,预防心脏病,现代医学研究认为,黄豆中还含有一种抑胰酶的物质,它对糖尿病有一定的疗效,因此,黄豆被营养学家推荐为防治冠心病,高血压动脉粥样硬化等疾病的理想保健品。
上述葵花子具有清肝泻火、养心安神作用,葵花子营养丰富,富含铁,能改善脱发、悦色美容。每100克葵花子中含有蛋白质23.1克、脂肪51.1克、糖9.6克、热量2169.4千焦、钙42毫克、磷334毫克、铁4.0毫克。葵花子含脂肪油可达50%左右,并含多量亚油酸(达70%),尚有磷脂、一谷甾醇等甾醇。亚油酸部分能抑制实验性血栓的形成,对预防高脂血症及血栓形成亦是有益的。
药用功效:调节人体新陈代谢、保持血压稳定及降低血中胆固醇,可防止不饱和脂肪酸在体内过度氧化,并活化毛细血管、促进血液循环,达到抗氧化、防衰老的效果。葵花子还能增强记忆力,预防癌症、忧郁症、失眠症和心血管等疾病的发生。
上述银耳可滋阴清热、通交心肾,银耳又叫白木耳,银耳含有丰富的蛋白质、脂肪和多种氨基酸、矿物质及肝糖。银耳中含有17种氨基酸,人体所必需的氨基酸中的3/4银耳都能提供。银耳含有多种矿物质,如钙、磷、铁、钾、钠、镁、硫等,其中钙、铁含量很高,在每百克银耳中,含钙643毫克,铁30.4毫克。此外,银耳中还含有海藻糖、甘露糖醇等肝糖,营养价值很高,是一种高级滋养补品;银耳能提高肝脏解毒能力,保护肝脏功能;银耳富有天然植物性胶质,加上它的滋阴作用,长期服用可以润肤,并有祛除脸部黄褐斑、雀斑的功效。
上述南瓜具有健脾益气、补血养心作用,南瓜性温、味甘、能保护胃粘膜,帮助消化,南瓜所含果胶还可以保护胃肠道粘膜,免受粗糙食品刺激,促进溃疡面愈合,适宜于胃病患者。南瓜所含成分能促进胆汁分泌,加强胃肠蠕动,帮助食物消化。
上述玉米富含脂类,能预防神经衰弱,玉米属于粗纤维,能加快肠胃的蠕动,其脂肪、磷元素、维生素B2的含量居谷类食物之首。但是玉米属于粗粮,在食用过程中应尽量做熟做烂,因为玉米粒外面的一层薄皮很不好消化,所以为了更好的吸收玉米所带来的营养,尽量做熟一些。玉米中富含的营养元素还能促进肠胃吸收,帮助肠胃蠕动,更好的保持肠胃的清洁,减少细菌带来的伤害。
上述红薯味甘,而且红薯肉色黄,五味中甘味入脾,五色中黄色入脾,而脾胃互为表里,所以红薯能有效补益脾胃,促进消化,强身健体,自古就有消化不良,红薯为粮的说法。
本发明所述的供神经衰弱患者食用的胶囊,其特征在于:所述胶囊粉剂中添加有蛋白质、B族维生素、维生素PP和维生素E。
本发明所述的供神经衰弱患者食用的胶囊,其特征在于:该胶囊采用了如下配方:牡蛎粉150份、海参粉100份、奶粉100份、鸡蛋粉80份、大豆粉80份、葵花子粉80份、银耳粉65份、南瓜粉65份、玉米粉50份、红薯粉50份。
由上可知,本发明与现有胶囊相比,有如下的优点。
本发明所述的供神经衰弱患者食用的胶囊,选用了优质牡蛎粉、海参粉、奶粉、鸡蛋粉、大豆、葵花子、银耳、南瓜、玉米、红薯原料,含有丰富的维生素A、E、B6、B12、叶酸和蛋白质、矿物质,如:钙、铁、磷、锌、铜、锰、钼、钾、钠、镁、硫等,对如今常见的神经衰弱、失眠有治疗、改善作用,经常服用,能补肾益精、养血养心、健脾益气,促进血液循环、促进消化,达到抗氧化、防衰老,强身健体的作用。
具体实施方式
为了彻底了解本发明,将在下列的描述中提出详细的配方组成。显然,本发明的施行并不限定于本领域的技术人员所熟习的特殊细节。本发明的较佳实施例详细描述如下,然而除了这些详细描述外,本发明还可以具有其他实施方式。
实施例1:一种供神经衰弱患者食用的胶囊及其生产工艺,其特征在于:所述胶囊采用了如下配方及其生产工艺。
步骤1:挑选优质的牡蛎粉、海参粉、奶粉、鸡蛋粉、大豆、葵花子、银耳、南瓜、玉米和红薯为原料;
步骤2:将大豆炒熟后放入粉碎机中,经粗磨、细磨后打磨成细粉,过100目筛。
步骤3:将葵花子炒熟后放入粉碎机中,经粗磨、细磨后打磨成细粉,过100目筛。
步骤4:将银耳烘干或晒干后,研磨成细粉,过100目筛。
步骤5:将南瓜经去皮去籽→磨浆→滤渣→煮浆→调配→均质→浓缩→喷雾干燥后,过100目筛,得南瓜粉。
步骤6:将玉米经磨浆→滤渣→煮浆→调配→均质→浓缩→喷雾干燥后,过100目筛,得玉米粉。
步骤7:将红薯经去皮→磨浆→滤渣→煮浆→调配→均质→浓缩→喷雾干燥后,过100目筛,得红薯粉。
步骤8:称取上述牡蛎粉150份、海参粉100份、奶粉100份、鸡蛋粉80份、大豆粉80份、葵花子粉80份、银耳粉65份、南瓜粉65份、玉米粉50份、红薯粉50份。
步骤9:将上述粉剂放入搅拌机中搅拌均匀后,经杀菌后在无菌环境中灌装成胶囊,每粒0.5克,经检验合格后得成品。
本发明所述的供神经衰弱患者食用的胶囊,选用了优质牡蛎粉、海参粉、奶粉、鸡蛋粉、大豆、葵花子、银耳、南瓜、玉米、红薯原料,含有丰富的维生素A、E、B6、B12、叶酸和蛋白质、矿物质,如:钙、铁、磷、锌、铜、锰、钼、钾、钠、镁、硫等,对如今常见的神经衰弱、失眠有治疗、改善作用,经常服用,能补肾益精、养血养心、健脾益气,促进血液循环、促进消化,达到抗氧化、防衰老,强身健体的作用。
本发明中的新型胶囊中主要原料的营养成分及功能如下。
上述牡蛎粉性微寒味咸与归经,归肝、胆、肾经,对神经衰弱、失眠有治疗、改善作用。《本草拾遗》:捣为粉,粉身,主大人小儿盗汗,和麻黄根、蛇床子、干姜为粉,去阴汗。《纲目》:化痰软坚,清热除湿,止心脾气痛,痢下,赤白浊,消疝瘕积块,瘿疾结核。
【功能与主治】重镇安神、潜阳补阴、软坚散结、收敛固涩,用于惊悸失眠、眩晕耳鸣、瘰疬痰核、自汗盗汗、遗精崩带、胃痛泛酸,能益阴潜阳,治阴虚阳亢之潮热、头痛、烦躁失眠等症。
上述海参粉由海参干制而成,对治疗神经衰弱、失眠有效果,海参的营养价值很高,蛋白质含量达70%,而胆固醇含量却较其它动物性食品都低,因此很适宜高血压病人食用。
中医认为,海参主人心、肺、脾、肾四经,是滋补气血津精的佳品。近年来发现,从海参中提取出的粘多糖,有抑制癌细胞生长和转移的功效;具有补肾益精,养血润肠的功效,适用于因肝肾亏损、精血不足引起的眩晕耳鸣、腰酸乏力、梦遗精、小便频繁者。
上述奶粉是由鲜牛奶消毒后经浓缩、喷雾、干燥而成的,具有健脾益气、补血养心作用,营养丰富,富含蛋白质、矿物质,如:钙、铁、磷、锌、铜、锰、钼以及维生素,可提供大脑所需的各种氨基酸,每天饮用可增强大脑活力。牛奶是一种近乎完美的营养品。它富含蛋白质、钙,及大脑所必需的氨基酸。牛奶中的钙最易被人吸收,是脑代谢不可缺少的重要物质。此外,它还含对神经细胞十分有益的维生素B1等元素。如果用脑过度而失眠时,睡前一杯热牛奶有助入睡。
上述鸡蛋粉由鸡蛋加工而成,有清肝泻火、养心安神作用,含有蛋黄素等脑细胞所必需的营养物质,可增强大脑活力。富含卵磷脂,是人体合成乙酰胆碱(负责记忆力的神经传导物质)的主要原料。此外,鸡蛋中也有丰富的维生素A、E、B6、B12、叶酸和锌等活化脑力很重要的营养素,尤其是叶酸和维生素B12。陆续有研究指出,如果长期缺乏这两种营养素,会使记忆力减退,甚至可能增加罹患失智症的机率。
上述大豆味甘、性平,入脾、大肠经,所含的卵磷脂是大脑细胞组成的重要部分,常吃黄豆对增加和改善大脑技能有重要的效能,且不含胆固醇,并可降低人体胆固醇,减少动脉硬化的发生,预防心脏病,现代医学研究认为,黄豆中还含有一种抑胰酶的物质,它对糖尿病有一定的疗效,因此,黄豆被营养学家推荐为防治冠心病,高血压动脉粥样硬化等疾病的理想保健品。
上述葵花子具有清肝泻火、养心安神作用,葵花子营养丰富,富含铁,能改善脱发、悦色美容。每100克葵花子中含有蛋白质23.1克、脂肪51.1克、糖9.6克、热量2169.4千焦、钙42毫克、磷334毫克、铁4.0毫克。葵花子含脂肪油可达50%左右,并含多量亚油酸(达70%),尚有磷脂、一谷甾醇等甾醇。亚油酸部分能抑制实验性血栓的形成,对预防高脂血症及血栓形成亦是有益的。
药用功效:调节人体新陈代谢、保持血压稳定及降低血中胆固醇,可防止不饱和脂肪酸在体内过度氧化,并活化毛细血管、促进血液循环,达到抗氧化、防衰老的效果。葵花子还能增强记忆力,预防癌症、忧郁症、失眠症和心血管等疾病的发生。
上述银耳可滋阴清热、通交心肾,银耳又叫白木耳,银耳含有丰富的蛋白质、脂肪和多种氨基酸、矿物质及肝糖。银耳中含有17种氨基酸,人体所必需的氨基酸中的3/4银耳都能提供。银耳含有多种矿物质,如钙、磷、铁、钾、钠、镁、硫等,其中钙、铁含量很高,在每百克银耳中,含钙643毫克,铁30.4毫克。此外,银耳中还含有海藻糖、甘露糖醇等肝糖,营养价值很高,是一种高级滋养补品;银耳能提高肝脏解毒能力,保护肝脏功能;银耳富有天然植物性胶质,加上它的滋阴作用,长期服用可以润肤,并有祛除脸部黄褐斑、雀斑的功效。
上述南瓜具有健脾益气、补血养心作用,南瓜性温、味甘、能保护胃粘膜,帮助消化,南瓜所含果胶还可以保护胃肠道粘膜,免受粗糙食品刺激,促进溃疡面愈合,适宜于胃病患者。南瓜所含成分能促进胆汁分泌,加强胃肠蠕动,帮助食物消化。
上述玉米富含脂类,能预防神经衰弱,玉米属于粗纤维,能加快肠胃的蠕动,其脂肪、磷元素、维生素B2的含量居谷类食物之首。但是玉米属于粗粮,在食用过程中应尽量做熟做烂,因为玉米粒外面的一层薄皮很不好消化,所以为了更好的吸收玉米所带来的营养,尽量做熟一些。玉米中富含的营养元素还能促进肠胃吸收,帮助肠胃蠕动,更好的保持肠胃的清洁,减少细菌带来的伤害。
上述红薯味甘,而且红薯肉色黄,五味中甘味入脾,五色中黄色入脾,而脾胃互为表里,所以红薯能有效补益脾胃,促进消化,强身健体,自古就有消化不良,红薯为粮的说法。
本发明所述的供神经衰弱患者食用的胶囊,其特征在于:所述胶囊粉剂中添加有蛋白质、B族维生素、维生素PP和维生素E。
实施例2:本发明所述的供神经衰弱患者食用的胶囊,其特征在于:该胶囊采用了如下配方:牡蛎粉180份、海参粉110份、奶粉90份、鸡蛋粉90份、大豆粉85份、葵花子粉100份、银耳粉70份、南瓜粉70份、玉米粉40份、红薯粉45份,其生产工艺同实施例1。
本发明所述的供神经衰弱患者食用的胶囊及其生产工艺已经通过上述实施例进行了说明,但应当理解的是,上述实施例只是用于举例和说明的目的,而非意在将本发明限制于所描述的实施例范围内。此外本领域技术人员可以理解的是,本发明并不局限于上述实施例,根据本发明的教导还可以做出更多种的变型和修改,这些变型和修改均落在本发明所要求保护的范围以内。本发明的保护范围由附属的权利要求书及其等效范围所界定。
Claims (3)
1.一种供神经衰弱患者食用的胶囊及其生产工艺,其特征在于:所述胶囊采用了如下配方及其生产工艺:
步骤1:挑选优质的牡蛎粉、海参粉、奶粉、鸡蛋粉、大豆、葵花子、银耳、南瓜、玉米和红薯为原料;
步骤2:将大豆炒熟后放入粉碎机中,经粗磨、细磨后打磨成细粉,过80-120目筛;
步骤3:将葵花子炒熟后放入粉碎机中,经粗磨、细磨后打磨成细粉,过80-120目筛;
步骤4:将银耳烘干或晒干后,研磨成细粉,过80-120目筛;
步骤5:将南瓜经去皮去籽→磨浆→滤渣→煮浆→调配→均质→浓缩→喷雾干燥后,过80-120目筛,得南瓜粉;
步骤6:将玉米经磨浆→滤渣→煮浆→调配→均质→浓缩→喷雾干燥后,过80-120目筛,得玉米粉;
步骤7:将红薯经去皮→磨浆→滤渣→煮浆→调配→均质→浓缩→喷雾干燥后,过80-120目筛,得红薯粉;
步骤8:称取上述牡蛎粉120-180份、海参粉80-120份、奶粉80-120份、鸡蛋粉60-100份、大豆粉60-100份、葵花子粉60-100份、银耳粉50-80份、南瓜粉50-80份、玉米粉40-60份、红薯粉40-60份;
步骤9:将上述粉剂放入搅拌机中搅拌均匀后,经杀菌后在无菌环境中灌装成胶囊,每粒0.25-0.5克,经检验合格后得成品。
2.根据权利要求1所述的供神经衰弱患者食用的胶囊,其特征在于:所述胶囊粉剂中添加有蛋白质、B族维生素、维生素PP和维生素E。
3.根据权利要求1所述的供神经衰弱患者食用的胶囊,其特征在于:该胶囊采用了如下配方:牡蛎粉150份、海参粉100份、奶粉100份、鸡蛋粉80份、大豆粉80份、葵花子粉80份、银耳粉65份、南瓜粉65份、玉米粉50份、红薯粉50份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310621903.7A CN103610056A (zh) | 2013-11-30 | 2013-11-30 | 供神经衰弱患者食用的胶囊及其生产工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310621903.7A CN103610056A (zh) | 2013-11-30 | 2013-11-30 | 供神经衰弱患者食用的胶囊及其生产工艺 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103610056A true CN103610056A (zh) | 2014-03-05 |
Family
ID=50160792
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310621903.7A Pending CN103610056A (zh) | 2013-11-30 | 2013-11-30 | 供神经衰弱患者食用的胶囊及其生产工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103610056A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106509904A (zh) * | 2016-10-28 | 2017-03-22 | 广东立美神健康科技有限公司 | 一种亚麻籽油微胶囊粉末 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1106264A (zh) * | 1994-02-02 | 1995-08-09 | 深圳海王集团股份有限公司 | 牡蛎提取物及其制剂的制备方法 |
CN1302561A (zh) * | 2001-01-16 | 2001-07-11 | 程显峰 | 牡蛎营养素及其制作方法 |
CN101828744A (zh) * | 2010-05-13 | 2010-09-15 | 大连蓝德奥科技有限公司 | 抗疲劳、提高免疫力的全营养高活性海参饮液及其制法 |
KR20120131980A (ko) * | 2011-05-27 | 2012-12-05 | 양민우 | 야채 쌈용 등푸른 생선의 제조 방법 및 등푸른 생선 야채 쌈 |
-
2013
- 2013-11-30 CN CN201310621903.7A patent/CN103610056A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1106264A (zh) * | 1994-02-02 | 1995-08-09 | 深圳海王集团股份有限公司 | 牡蛎提取物及其制剂的制备方法 |
CN1302561A (zh) * | 2001-01-16 | 2001-07-11 | 程显峰 | 牡蛎营养素及其制作方法 |
CN101828744A (zh) * | 2010-05-13 | 2010-09-15 | 大连蓝德奥科技有限公司 | 抗疲劳、提高免疫力的全营养高活性海参饮液及其制法 |
KR20120131980A (ko) * | 2011-05-27 | 2012-12-05 | 양민우 | 야채 쌈용 등푸른 생선의 제조 방법 및 등푸른 생선 야채 쌈 |
Non-Patent Citations (3)
Title |
---|
刘勇谋: "《现代家庭营养大全》", 31 December 2006, article "神经衰弱的饮食治疗", pages: 522-524 * |
蔡树涛: "《常见慢性病自然疗法系列-神经衰弱和失眠》", 31 May 2000, article "适用于神经衰弱和失眠患者的天然食物", pages: 242-250 * |
赵映前: "《神经衰弱的中医调补》", 30 September 2009, article "神经衰弱患者为什么要注意补充营养", pages: 113-114 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106509904A (zh) * | 2016-10-28 | 2017-03-22 | 广东立美神健康科技有限公司 | 一种亚麻籽油微胶囊粉末 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107173694A (zh) | 一种营养全面平衡的全素食代餐粉配方 | |
CN102224891B (zh) | 一种糖醇蜂蜜苹果酱及其制备方法 | |
CN102178183A (zh) | 一种五豆综合营养食品 | |
CN104473174B (zh) | 一种糖尿病专用营养全麦粉制作工艺 | |
CN104855994A (zh) | 肾病非全营养配方食品 | |
CN102048225B (zh) | 一种具有改善生长发育功能的红枣保健饮料 | |
CN101785542B (zh) | 参杞五谷养生馒头 | |
CN105533688A (zh) | 一种辅助降血糖保健软胶囊及其制备方法 | |
CN105918387A (zh) | 一种适用中老年保健食品及制备方法 | |
CN105962349A (zh) | 一种小儿益智保健食品 | |
CN103610144A (zh) | 一种降糖核桃粉及其制备方法 | |
CN107691794A (zh) | 一种蝴蝶犬幼犬狗粮及其制备方法 | |
CN103637093A (zh) | 一种安神补脑的新型燕麦片冲剂及其加工方法 | |
CN104824674A (zh) | 一种防治脱发的营养保健食品 | |
CN103610057A (zh) | 一种提神健脑的含片 | |
CN105380073A (zh) | 一种糖尿病营养餐冲剂 | |
CN100574786C (zh) | 一种甲鱼制剂的生产工艺 | |
CN108782679A (zh) | 一种减肥干预代餐饼干及其制备方法 | |
CN103621883A (zh) | 一种改善脂肪肝的燕麦片及制备方法 | |
CN113558227A (zh) | 一种多种营养成分的黑芝麻糊及其制备方法 | |
CN101675800B (zh) | 一种妇女产后滋补膏及制备方法 | |
KR20120066380A (ko) | 사슴뼈의 분말을 이용한 한방 건강보조식품 | |
CN108308523A (zh) | 一种排毒养颜代餐粉 | |
CN103610056A (zh) | 供神经衰弱患者食用的胶囊及其生产工艺 | |
CN103766758A (zh) | 一种土豆糯米糕及其制作方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140305 |